Stamford, CT -- (SBWIRE) -- 12/16/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Avatar Ventures Corp (OTCMKTS:ATAR), Globalstar, Inc.(OTCMKTS:GSAT) , Applied DNA Sciences Inc(OTCMKTS:APDN), STEM CELL THERAPEUTI(OTCMKTS:SCTPF)
Avatar Ventures Corp (OTCMKTS:ATAR) increased 101.66% at the price of $0.0365 recently on a traded volume of 1.04 million shares, in comparison to 16,705.00 shares of average trading volume. So far this year, the stock is up over 101.66%.
The company has a total market capitalization of $2.51 million and its total outstanding shares are 68.63 million. Avatar Ventures Corp. is a development-stage company. The Company focuses to be a developer of aftermarket electronic accessories for consumer motor vehicles. The Company's product in development is a cellular phone car adapter, which enables to cellular text messages and wireless e-mails to be displayed on a liquid crystal display (LCD) screen attached to the car's dashboard area.
For How Long ATAR will Fight for Profitability? Read This Trend Analysis report
Globalstar, Inc.(OTCMKTS:GSAT) plunged -1.02% at the trading price of $1.95 on a traded volume of 1.08 million shares till now, whereas its average trading volume is 4.54million shares. In the last three months, the stock is up 100%. The Intra-day range for the stock is $1.92 and $2.02. Globalstar, Inc. (Globalstar) is a provider of mobile voice and data communications services globally via satellite. Globalstar’s satellite communications business, by providing critical mobile communications to the Company's subscribers, serves principally recreation and personal; government.
Has GSAT Found The Bottom And Ready To Gain Momentum? Find Out Here
Applied DNA Sciences Inc(OTCMKTS:APDN) jumped up 4.76% at the $0.178 recently. So far in three months, the stock is up 49.66%. The 52-week range for the stock is $0.08 and $0.31. Its introductory price for the day was $0.18, with the overall traded volume of 3.07 million shares.
Applied DNA Sciences, Inc. is a provider of botanical-deoxyribonucleic acid (DNA) based security and authentication solutions that can help protect products, brands and property of companies, governments and consumers from theft, counterfeiting, fraud and diversion.
Will APDN Continue To Move Higher? Find Out Here
STEM CELL THERAPEUTI(OTCMKTS:SCTPF), after opening its shares at the price of $0.30, jumped up 25.22% , its recent trading price was $0.338 for the day. The stock moved on a traded volume of 1.00 million shares, in comparison to 14,174.00 shares of average trading volume. The 52-week range for the stock is $0.14 and $0.48. Its introductory price for the day was $0.30. Stem Cell Therapeutics Corp., a biopharmaceutical development company, develops and commercializes stem cell-based therapies for cell therapy and regenerative medicine. Its products include Tigecycline, which is in phase I for study in patients with relapsed or refractory acute myeloid leukemia (AML).
Why Should Investors Buy SCTPF After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)